Argitalpenak (81) MARTA TRAPERO BERTRAN argitalpenak

2024

  1. Effects of C-reactive protein rapid testing and communication skills training on antibiotic prescribing for acute cough. A cluster factorial randomised controlled trial

    npj Primary Care Respiratory Medicine, Vol. 34, Núm. 1

  2. Palliative Care Costs in Different Ambulatory-Based Settings: A Systematic Review

    PharmacoEconomics, Vol. 42, Núm. 3, pp. 301-318

2023

  1. Cost-effectiveness and cost-utility analyses of a web-based computer-tailored intervention for prevention of binge drinking among Spanish adolescents

    Alcoholism: Clinical and Experimental Research, Vol. 47, Núm. 2, pp. 319-335

  2. Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 1, pp. 243-252

  3. Estimating ambient air pollution mortality and disease burden and its economic cost in Barcelona

    Environmental Research, Vol. 216

  4. Evaluaciones económicas de intervenciones dirigidas a la prevención, tratamiento y/o rehabilitación de trastornos por consumo de alcohol: una revisión sistemática

    Adicciones: Revista de socidrogalcohol, Vol. 35, Núm. 3, pp. 325-348

  5. Exposure to secondhand and thirdhand smoke in private vehicles: Measurements in air and dust samples

    Environmental Research, Vol. 235

  6. Measurement of airborne nicotine, as a marker of secondhand smoke exposure, in homes with residents who smoke in 9 European countries

    Environmental Research, Vol. 219

  7. Posttransplant Hepatocellular Carcinoma Surveillance: A Cost-effectiveness and Cost-utility Analysis

    Annals of Surgery, Vol. 277, Núm. 2, pp. E359-E365

  8. Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper

    Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1

2022

  1. A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System

    International Journal of COPD, Vol. 17, pp. 1431-1442

  2. Estadísticas del gasto sanitario: tenemos que arreglar este embrollo

    Economía y salud: boletín informativo, Núm. 99, pp. 17-21

  3. Research can be integrated into public health policy-making: global lessons for and from Spanish economic evaluations

    Health Research Policy and Systems, Vol. 20, Núm. 1

2021

  1. Burden of disease from exposure to secondhand smoke in children in Europe

    Pediatric Research, Vol. 90, Núm. 1, pp. 216-222

  2. Burden of disease from second-hand tobacco smoke exposure at home among adults from European Union countries in 2017: an analysis using a review of recent meta-analyses

    Preventive Medicine, Vol. 145

  3. Direct health care costs associated to neurological diseases and different degrees of malnutrition

    Clinical Nutrition ESPEN, Vol. 44, pp. 297-305

  4. Economic evaluation of a multimodal intervention in pre-frail and frail older people with diabetes mellitus: the MID-FRAIL project

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 1, pp. 111-118

  5. Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: A model-based cost-effectiveness analysis

    Lung Cancer, Vol. 159, pp. 153-161

  6. Menores y adolescentes sin alcohol: una perspectiva epidemiológica, económica y jurídica.

    Documentos de trabajo (Laboratorio de alternativas)

  7. Resource utilization and outcomes in emergency general surgery during the COVID19 pandemic: An observational cost analysis

    PLoS ONE, Vol. 16, Núm. 6 June